Applied DNA launches RT-PCR test for COVID-19

By LabPulse.com staff writers

May 14, 2020 -- Applied DNA Sciences has received emergency use authorization from the U.S. Food and Drug Administration for a real-time reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.

The company's Linea COVID-19 RT-PCR test kit detects genetic sequences of SARS-CoV-2 from upper respiratory specimens. The assay runs on the Applied Biosystems QuantStudio Dx RT-PCR system, which can provide test results for up to 94 samples in one hour.

The RT-PCR was designed for CLIA-certified laboratories that require rapid, high-volume testing, according to the company. The product is now available for ordering.

Eurofins debuts real-time RT-PCR test for COVID-19
Eurofins Technologies has announced the launch of a multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.
Opti Medical gets EUA for COVID-19 molecular diagnostic
Opti Medical Systems has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its molecular novel coronavirus laboratory...
BioIQ, Matrix Medical promote employer COVID-19 testing program
BioIQ and Matrix Medical Network are combining expertise to help U.S. companies make it safer for their employees to return to work when the COVID-19...
Centene, Quest to distribute COVID-19 test kits
Centene and Quest Diagnostics are teaming up to increase access to real-time reverse transcription polymerase chain reaction COVID-19 tests.
COVID-19 testing presents learning curve for all involved
For most aspects of the COVID-19 diagnostic testing process, there has been a learning curve for all involved. But creative solutions have been emerging...

Copyright © 2020 LabPulse.com

Last Updated ls 5/14/2020 1:52:05 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current